Chickadee Biomedicines reported raising $1 Million in an initial SEC Form D filing, from an offering of $1 Million
Round Type
Seed
New YorkBiotechnologyQuick answer
Chickadee Biomedicines raised $1 Million in a Seed round, dated October 28, 2026. Chickadee Biomedicines is based in New York, New York, United States.
- How much did Chickadee Biomedicines raise?
- Chickadee Biomedicines raised $1 Million in a Seed round on October 28, 2026.
- Where is Chickadee Biomedicines based and how big is it?
- Chickadee Biomedicines is based in New York, New York, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Chickadee Biomedicines that raised within 45 days of this round, from Fundz verified event records.
- Efferon raised $4.8M (Seed) on November 10, 2026.
- Nanopath raised $25M (Series B) on November 10, 2026.
- Oyster Therapeutics raised $60M (Series A) on November 10, 2026.
- Neobe raised $6.8M on November 10, 2026.
- MyoWorks raised an undisclosed amount on November 10, 2026.
- EnVision Endoscopy raised $12M (Series A) on November 10, 2026.
Who to call at Chickadee Biomedicines, and when
A new round usually means Chickadee Biomedicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Chickadee Biomedicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Chickadee Biomedicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Chickadee Biomedicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Chickadee Biomedicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Chickadee Biomedicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.